Effect of celecoxib and cisplatin combination on apoptosis and cell proliferation in a mouse model of chemically-induced colonic aberrant crypt foci

References

• J.FerlayH.R.ShinF.Braet al.Estimates of worldwide burden of cancer in 2008: GLOBOCANInt J Cancer127201028932917
   PubMed Web of Science ®Google Scholar
• Freedman LS, Edwards BK, Ries LAG, Young JL, editors. National Cancer Institute (US), Middle East Cancer Consortium. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. Bethesda, MD: National Cancer Institute, 2006.
   Google Scholar
• T.T.NieminenS.ShomanS.EissaP.PeltomäkiW.M.Abdel-RahmanDistinct genetic and epigenetic signatures of colorectal cancers according to ethnic originCancer Epidemiol Biomarkers Prev212012202211
   Web of Science ®Google Scholar
• D.VeruttipongA.SolimanS.Gilbertet al.Age distribution, polyps, and rectal cancer in the Egyptian population-based cancer registryWorld J Gastroenterol18201239974003
   PubMed Web of Science ®Google Scholar
• A.GadoB.EbeidA.AbdelmohsenA.AxonColorectal cancer in Egypt is commoner in young people: Is this cause for alarm?Alex J Med502014197201
   Google Scholar
• J.R.JassPathogenesis of Colorectal CancerSurg Clin North Am822002891904
   Web of Science ®Google Scholar
• L.ChengM.D.LaiAberrant crypt foci as microscopic precursors of colorectal cancerWorld J Gastroenterol9200326422649
   PubMed Web of Science ®Google Scholar
• M.SuzuiT.MoriokaN.YoshimiColon preneoplastic lesions in animal modelsJ Toxicol Pathol262013335341
   PubMed Web of Science ®Google Scholar
• R.P.BirdRole of aberrant crypt foci in understanding the pathogenesis of colon cancerCancer Lett9319955571
   PubMed Web of Science ®Google Scholar
• R.N.DuboisS.B.AbramsonL.Croffordet al.Cyclooxygenase in biology and diseaseFASEB J12199810631073
   PubMed Web of Science ®Google Scholar
• R.A.GuptaR.N.DuBoisColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2Nat Rev Cancer11–212011
   Google Scholar
• L.J.MarnettR.N.DuBoisCOX-2: a target for colon cancer preventionAnnu Rev Pharmacol Toxicol4220025580
   PubMed Web of Science ®Google Scholar
• N.KawaiM.TsujiiS.TsujiCyclooxygenases and colon cancerProstaglandins Other Lipid Mediat68–692002187196
   PubMed Web of Science ®Google Scholar
• M.OshimaJ.E.DinchukS.L.Kargmanet al.Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)Cell871996803809
   PubMed Web of Science ®Google Scholar
• S.GroschI.TegederE.NiederbergerL.BrautigamG.GeisslingerOX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxibFASEB J15200127422744
   PubMed Web of Science ®Google Scholar
• R.A.AlderdenM.D.HallT.W.HambleyThe discovery and development of cisplatinJ Chem Educ832006728734
   Web of Science ®Google Scholar
• G.SteinbachP.M.LynchR.K.PhillipsM.H.WallaceE.Hawket al.The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisN Engl J Med342200019461952
   PubMed Web of Science ®Google Scholar
• A.L.HsuT.T.ChingD.S.WangX.SongV.M.RangnekarC.S.ChenThe cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2J Biol Chem27520001139711403
   PubMed Web of Science ®Google Scholar
• S.IshidaJ.LeeD.J.ThieleI.HerskowitzUptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammalsProc Natl Acad Sci USA9920021429814302
   PubMed Web of Science ®Google Scholar
• C.ColussiS.FiumicinoA.Giulianiet al.1,2-Dimethylhydrazine-induced colon carcinoma and Lymphoma in msh2−/− miceJNCI93200115341540
   Google Scholar
• JDBancroftA.StevensTheory and practice of histological techniques4th Ed.1996Churchill LivingstoneNew York and London (pp. 145–146)
   Google Scholar
• D.K.ZaafarS.A.ZaitoneY.M.MoustafaRole of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferationPLoS ONE92014e100562
   PubMed Web of Science ®Google Scholar
• A.GaikwadJ.T.PrchalStudy of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia veraExp Hematol35200716471656
   Web of Science ®Google Scholar
• P.E.JacksonD.P.CooperP.J.O’ConnorA.C.PoveyThe relationship between 1,2-dimethylhydrazine dose and the induction of colon tumours: tumour development in female SWR mice does not require a K-ras mutational eventCarcinogenesis201999509513
   Web of Science ®Google Scholar
• T.P.PretlowB.J.BarrowW.S.Ashtonet al.Aberrant crypts: putative preneoplastic foci in human colonic mucosaCancer Res51199115641567
   PubMed Web of Science ®Google Scholar
• M.J.WargovichMc.Kee K.JimenezAet al.Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progressionCarcinogenesis21200011491155
   PubMed Web of Science ®Google Scholar
• G.P.BoivinK.WashingtonK.Yanget al.Pathology of mouse models of intestinal cancer: consensus report and recommendationsGastroenterology1242003762777
   PubMed Web of Science ®Google Scholar
• J.RajuAzoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancerWorld J Gastroenterol14200866326635
   PubMed Web of Science ®Google Scholar
• B.YangT.S.JohnsonG.L.Thomaset al.A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritisKidney Int62200213011313
   PubMed Web of Science ®Google Scholar
• C.CarrilloM.CaviaMdelS.R.Alonso-TorreAntitumor effect of oleic acid; mechanism of action: a reviewNutr Hosp27201218601865
   PubMed Web of Science ®Google Scholar
• DQZhangQGuoJHZhuWCChenIncrease of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancerWorld J Surg Oncol20131116
   Web of Science ®Google Scholar
• S.AmptoulachA.C.LazarisI.Giannopoulouet al.Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancerMed Oncol322015416
   Web of Science ®Google Scholar
• M.GallicchioA.C.RosaC.DianzaniL.BrucatoM.CollinoR.FantozziCelecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)Br J Pharmacol1532008870878
   PubMed Web of Science ®Google Scholar
• Y.ChenY.TsaiS.TsengCombined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cellsAnticancer Res31201122312240
   PubMed Web of Science ®Google Scholar
• Y.JeonY.J.SuhSynergistic apoptotic effect of celecoxib and luteolin on breast cancer cellsOncol Rep292013819825
   PubMed Web of Science ®Google Scholar
• V.JendrossekTargeting pathways of celecoxib in cancerCancer lett3322013313324
   PubMed Web of Science ®Google Scholar
• C.RosasM.SinningA.Ferreiraet al.Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapyBiol Res47201427
   PubMed Web of Science ®Google Scholar
• F.A.SinicropeG.RoddeyT.J.McDonnellY.ShenK.R.ClearyL.C.StephensIncreased apoptosis accompanies neoplastic development in the human colorectumClin Cancer Res2199619992006
   Web of Science ®Google Scholar
• M.X.LinZ.F.WenZ.Y.FengD.HeExpression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissuesChin J Cancer272008568573
   Google Scholar